Syngen Biotech Co.,Ltd.
Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sa… Read more
Market Cap & Net Worth: Syngen Biotech Co.,Ltd. (8279)
Syngen Biotech Co.,Ltd. (TWO:8279) has a market capitalization of $30.85K (NT$1.02 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #43012 globally and #1926 in its home market, demonstrating a -1.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Syngen Biotech Co.,Ltd.'s stock price NT$111.50 by its total outstanding shares 9155 (9.15K).
Syngen Biotech Co.,Ltd. Market Cap History: 2025 to 2026
Syngen Biotech Co.,Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $32.10K to $30.85K (0.00% CAGR).
Syngen Biotech Co.,Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Syngen Biotech Co.,Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8279 by Market Capitalization
Companies near Syngen Biotech Co.,Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Syngen Biotech Co.,Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Syngen Biotech Co.,Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, Syngen Biotech Co.,Ltd.'s market cap moved from $32.10K to $ 30.85K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$30.85K | -3.88% |
| 2025 | NT$32.10K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Syngen Biotech Co.,Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.85K USD |
| MoneyControl | $30.85K USD |
| MarketWatch | $30.85K USD |
| marketcap.company | $30.85K USD |
| Reuters | $30.85K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.